PDF icon PDF herunterladen
Semin Neurol 2023; 43(05): 768-775
DOI: 10.1055/s-0043-1775751
Review Article

Disease-Based Prognostication: Neuro-Oncology

Kristin A. Waite   *
1   Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, National Cancer Institute, Bethesda, Maryland
2   Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois
,
Gino Cioffi   *
1   Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, National Cancer Institute, Bethesda, Maryland
2   Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois
,
Mark G. Malkin   **
3   Cleveland Clinic, Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland, Ohio
,
Jill S. Barnholtz-Sloan   **
1   Division of Cancer Epidemiology and Genetics, Trans-Divisional Research Program, National Cancer Institute, Bethesda, Maryland
2   Central Brain Tumor Registry of the United States (CBTRUS), Hinsdale, Illinois
4   Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints
Preview

Abstract

Primary malignant and non-malignant brain and other central nervous system (CNS) tumors, while relatively rare, are a disproportionate source of morbidity and mortality. Here we provide a brief overview of approaches to modeling important clinical outcomes, such as overall survival, that are critical for clinical care. Because there are a large number of histologically distinct types of primary malignant and non-malignant brain and other CNS tumors, this chapter will provide an overview of prognostication considerations on the most common primary non-malignant brain tumor, meningioma, and the most common primary malignant brain tumor, glioblastoma. In addition, information on nomograms and how they can be used as individualized prognostication tools by clinicians to counsel patients and their families regarding treatment, follow-up, and prognosis is described. The current state of nomograms for meningiomas and glioblastomas are also provided.

Keywords

meningioma - glioblastoma - clinical outcomes - nomogram - biomarkers

* These authors share first authorship.


** These authors jointly supervised this work and share senior authorship.




Publikationsverlauf

Artikel online veröffentlicht:
26. September 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA